RXRX Bam just like that back below the ma on the weekly. Took a year to get over and dropped like a sack by institutional shorts in a few days. Probably hobble around here for another year between 8 and 6.
RECURSION PHARMACEUTICALS INC stock forum
RXRX Bam just like that back below the ma on the weekly. Took a year to get over and dropped like a sack by institutional shorts in a few days. Probably hobble around here for another year between 8 and 6.
RXRX is getting ready to melt up soon. Starting to look a lot like RKLB and MSTR before they blew up. Don't forget NVDA invested in this.
RXRX Earnings quite a disappointment to the market. Much higher loss than expected and revenue as well (although they say that's due to a timing issue of when they get their payments from collaborations). Regardless of that, with it's valuation compared where it is in the revenue journey I could see this go quite a lot lower than the 10% it's down pre market. Especially if AI and the market in general is having a major correction. I'll probably sell at the next pull back higher. We do seem to be due some sort of rise very shortly and earnings often do happen to make at least short term turns in price action.
RXRX when is earnings?RXRX we covered the gap.RXRX tradingview.com/x/4UaiFfq0let's see today
RXRX Going to turn negative for the day.RXRX Getting murdered by shorts.RXRX tradingview.com/x/PWt2TuUr....its the 15 minute, but let's see how this transpires into the hourly and further.
RXRX On Friday, NVDA filed a regulatory report detailing changes in its stock holdings, including reductions and increases in various investments. Notably, the company maintained its 7.7 million shares in RXRX while divesting from firms such as SoundHound AI.
NVDA 
SPX 
NDX 
DXY